OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea flag South Korea · Delayed Price · Currency is KRW
54,300
+4,200 (8.38%)
May 30, 2025, 3:30 PM KST

OliX Pharmaceuticals Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Revenue
5,8855,67717,0649,3203,6742,474
Upgrade
Revenue Growth (YoY)
-62.21%-66.73%83.09%153.66%48.50%118.90%
Upgrade
Cost of Revenue
264.71248.67159.88206.95171.7758.52
Upgrade
Gross Profit
5,6215,42816,9049,1133,5032,416
Upgrade
Selling, General & Admin
13,45814,44414,17812,34611,4888,227
Upgrade
Research & Development
18,92619,53618,47817,37914,9929,478
Upgrade
Other Operating Expenses
624.73591.19570.74657.94395.85310.7
Upgrade
Operating Expenses
34,68936,34735,09031,48927,73118,657
Upgrade
Operating Income
-29,068-30,919-18,185-22,376-24,229-16,241
Upgrade
Interest Expense
-4,703-4,661-3,492-2,930-2,431-239.07
Upgrade
Interest & Investment Income
442.23538.051,2861,396476.04250.55
Upgrade
Earnings From Equity Investments
-8,012-8,223-900.91---
Upgrade
Currency Exchange Gain (Loss)
-343.56-386.1814.62-127.59-23-14.69
Upgrade
Other Non Operating Income (Expenses)
-3,618582.032,335-5,054-3,675-775.5
Upgrade
EBT Excluding Unusual Items
-45,303-43,069-18,943-29,092-29,881-17,020
Upgrade
Gain (Loss) on Sale of Investments
271.06349.21438.97-36.1211.17-3,491
Upgrade
Gain (Loss) on Sale of Assets
-429.581,649-87.4820.34-416.83-
Upgrade
Other Unusual Items
--421.58-289.29-
Upgrade
Pretax Income
-45,462-41,071-18,170-29,108-29,997-20,511
Upgrade
Income Tax Expense
56.96-411.97932.07-994.9-821.54-1,126
Upgrade
Earnings From Continuing Operations
-45,519-40,659-19,102-28,113-29,176-19,385
Upgrade
Earnings From Discontinued Operations
---6,225-1,102-
Upgrade
Net Income to Company
-45,519-40,659-19,102-21,888-30,278-19,385
Upgrade
Minority Interest in Earnings
---2,392563.24-
Upgrade
Net Income
-45,519-40,659-19,102-19,495-29,715-19,385
Upgrade
Net Income to Common
-45,519-40,659-19,102-19,495-29,715-19,385
Upgrade
Shares Outstanding (Basic)
171714141413
Upgrade
Shares Outstanding (Diluted)
171714141413
Upgrade
Shares Change (YoY)
15.29%16.73%5.30%0.13%4.06%1.00%
Upgrade
EPS (Basic)
-2613.56-2413.98-1323.81-1422.69-2171.18-1473.86
Upgrade
EPS (Diluted)
-2613.58-2414.00-1324.00-1422.69-2171.18-1474.00
Upgrade
Free Cash Flow
-34,437-41,510-29,995-32,916-20,344-4,546
Upgrade
Free Cash Flow Per Share
-1977.25-2464.51-2078.73-2402.08-1486.45-345.62
Upgrade
Gross Margin
95.50%95.62%99.06%97.78%95.33%97.64%
Upgrade
Operating Margin
-493.91%-544.62%-106.57%-240.07%-659.40%-656.41%
Upgrade
Profit Margin
-773.43%-716.18%-111.94%-209.17%-808.70%-783.45%
Upgrade
Free Cash Flow Margin
-585.13%-731.17%-175.77%-353.16%-553.66%-183.72%
Upgrade
EBITDA
-26,453-28,292-15,543-20,301-22,599-15,101
Upgrade
EBITDA Margin
---91.09%-217.81%--
Upgrade
D&A For EBITDA
2,6152,6262,6422,0751,6301,141
Upgrade
EBIT
-29,068-30,919-18,185-22,376-24,229-16,241
Upgrade
EBIT Margin
---106.57%-240.07%--
Upgrade
Advertising Expenses
-5877.8273.7463.8895.55
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.